Stay updated on Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.

Latest updates to the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page
- CheckyesterdayChange DetectedSite revision updated from v3.4.0 to v3.4.1; no observable changes to study details or user-facing content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check23 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4; the study details and other content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded a Locations section listing North Carolina, Texas, and Virginia; updated the page revision to v3.3.3.SummaryDifference0.4%

- Check74 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2, a minor maintenance change with no substantive study content altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedRemoved the banner about government funding lapse and operating status; no study data or links were changed.SummaryDifference0.4%

- Check96 days agoChange DetectedArms B and C are closed to enrollment, and Arm A remains open for enrollment.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Nab-paclitaxel Consolidation Clinical Trial page.